Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Tolerability of CHF 1535 vs Symbicort in Moderate to Severe Persistent Asthma
NCT00413387Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Sep 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 3 trial of beclomethasone dipropionate, formoterol in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Sep 2004; status: completed.
02
Drugs
beclomethasone dipropionateformoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00413387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00413387.